Sanofi Discontinues C. Difficile Reference Sanofi d
Posted: Thu Dec 14, 2017 10:25 pm
Sanofi Discontinues C. Difficile Tx Development
Monthly Prescribing Reference
Sanofi has decided to discontinue the clinical development of its proposed Clostridium difficile vaccine after an interim analysis concluded that the probability of the Phase 3 study meeting its primary objective was low. The interim analysis was conducted by the Independent Data Monitoring Committee ...
Monthly Prescribing Reference
Sanofi has decided to discontinue the clinical development of its proposed Clostridium difficile vaccine after an interim analysis concluded that the probability of the Phase 3 study meeting its primary objective was low. The interim analysis was conducted by the Independent Data Monitoring Committee ...